Synthesis and SAR Studies of Isoquinoline and Tetrahydroisoquinoline Derivatives as Melatonin Receptor Ligands

ChemMedChem. 2022 Feb 4;17(3):e202100658. doi: 10.1002/cmdc.202100658. Epub 2021 Dec 1.

Abstract

In our constant search for new successors of agomelatine, we report herein a new series of compounds resulting from bioisosteric modulation of the naphthalene ring. The isoquinoline and tetrahydroisoquinoline derivatives were synthesized and pharmacologically evaluated. This isosteric replacement of the naphthalene group of agomelatine has led to potent agonist and partial agonist compounds with nanomolar melatonergic binding affinities. Overall, the presence of a nitrogen atom was accompanied with a decrease in the binding affinity toward both MT1 and MT2 and the loss of 5HT2C response, especially for tetrahydroisoquinoline in comparison with the parent compound. Interestingly, due to the presence of this nitrogen atom, a notable improvement in the pharmacokinetic properties was observed for all compounds.

Keywords: MT1/MT2; agomelatine; isoquinoline; melatonin; tetrahydroisoquinoline.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Cricetulus
  • Dose-Response Relationship, Drug
  • Humans
  • Isoquinolines / chemistry
  • Isoquinolines / metabolism
  • Isoquinolines / pharmacology*
  • Ligands
  • Molecular Docking Simulation
  • Molecular Structure
  • Receptors, Melatonin / agonists*
  • Structure-Activity Relationship

Substances

  • Isoquinolines
  • Ligands
  • Receptors, Melatonin
  • isoquinoline